BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36362947)

  • 1. The Regulation of the Hippo Pathway by Intercellular Junction Proteins.
    Ahmad US; Uttagomol J; Wan H
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions.
    Huang Y; Ahmad US; Rehman A; Uttagomol J; Wan H
    Life (Basel); 2022 May; 12(6):. PubMed ID: 35743822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
    Cho YS; Jiang J
    Front Cell Dev Biol; 2021; 9():658481. PubMed ID: 33869224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of YAP in the control of the metastatic potential of oral cancer.
    Ahmad US; Saravanan K; Wan H
    Oncol Res; 2021; 29(6):377-391. PubMed ID: 37304649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
    Ahmad US; Parkinson EK; Wan H
    Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules.
    Yang CC; Graves HK; Moya IM; Tao C; Hamaratoglu F; Gladden AB; Halder G
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1785-90. PubMed ID: 25624491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.
    Raghunathan VK; Dreier B; Morgan JT; Tuyen BC; Rose BW; Reilly CM; Russell P; Murphy CJ
    PLoS One; 2014; 9(10):e109811. PubMed ID: 25290150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
    Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
    Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications.
    Sun T; Chi JT
    Genes Dis; 2021 May; 8(3):241-249. PubMed ID: 33997171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.
    Uttagomol J; Ahmad US; Rehman A; Huang Y; Laly AC; Kang A; Soetaert J; Chance R; Teh MT; Connelly JT; Wan H
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of cellular responses to mechanical cues through YAP/TAZ regulation.
    Dasgupta I; McCollum D
    J Biol Chem; 2019 Nov; 294(46):17693-17706. PubMed ID: 31594864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.